Pyxis Oncology Inc.
PYXS | NASDAQ
$3.34
+$0.15 (+4.70%)
Sep 22, 2026, 10:41 AM ET · Market open
Market Data
Market Cap $202.1M
Enterprise Value $186.94M
Beta 1.34
Average Volume 1.05M
Shares Outstanding (Diluted) 63.99M
Shares Change YoY 3.35%
Institutional Ownership 43.44%
Exchange NASDAQ
ISIN US7473241013
Price Performance
Price Change 1M 4.6%
Price Change 3M 51.9%
Price Change 6M 123.1%
Price Change YTD 177.4%
Price Change 1Y 47.0%
Price Change 3Y 99.4%
Price Change 5Y -75.8%
1M CAGR (ann.) -14.5%
1Y CAGR (ann.) 37.5%
5Y CAGR (ann.) N/A
All-Time CAGR -24.9%
Valuation
PE Ratio -2.26
Forward PE N/A
PEG Ratio -0.30
Forward PEG 0.30
PS Ratio 18.31
Forward PS 64.70
PB Ratio 17.67
P/FCF Ratio -2.98
P/Adj. FCF Ratio -2.53
P/OCF Ratio -3.01
EV/Sales 16.94
EV/EBIT -2.13
EV/EBITDA -2.24
EV/FCF -2.75
Earnings Yield -44.2%
FCF Yield -33.6%
Adj. FCF Yield -39.5%
Financial Health
Net Cash $15.16M
Total Debt $17.83M
Cash & Short-Term Investments $33M
Total Assets $54.92M
Current Ratio 1.34
Quick Ratio 1.34
Debt / Equity Ratio 1.56
Debt / EBITDA -0.21
Debt / FCF -0.26
OCF / Debt -3.81
Interest Coverage 0.00
Altman Z-Score -14.61
Piotroski F-Score 2
Margins & Profitability
Gross Profit Margin 99.8%
Operating Profit Margin -834.4%
EBITDA Margin -755.9%
Net Profit Margin -803.8%
FCF Margin -615.3%
Adj. FCF Margin -723.1%
SBC / Revenue 107.8%
SBC Impact (per share) -17.5%
Returns
Return on Assets -161.6%
Return on Equity -215.2%
Return on Invested Capital -314.7%
Return on Capital Employed -335.6%
Return on Tangible Assets -161.6%
Historical Growth (CAGR)
Revenue CAGR 3Y -25.5%
Revenue CAGR 5Y 41.5%
Revenue CAGR 10Y N/A
EPS CAGR 3Y -5.3%
EPS CAGR 5Y 19.6%
EPS CAGR 10Y N/A
FCF CAGR 3Y -8.4%
FCF CAGR 5Y 3.0%
FCF CAGR 10Y N/A
Analyst Forecasts
Analyst Rating Buy
Analyst Count 12
EPS Growth Next 3Y 9.2%
Revenue Growth Next 3Y 57.0%
Earnings Date Nov 1, 2026
EPS Estimate (next Q) -$0.27
EPS Growth Est (next Q) -22.9%
Revenue Est (next Q) N/A
Revenue Growth Est (next Q) N/A
Fair Value Estimates
Graham Number N/A
Graham Upside N/A
Lynch Fair Value N/A
Lynch Upside N/A
Price Target $7.67
Price Target Upside 140.4%
Cash Flow
Operating Cash Flow $-67.91M
Free Cash Flow $-67.92M
Adj. Free Cash Flow $-79.81M
FCF Per Share -$1.06
OCF Per Share -$1.06
OCF/S Ratio -615.2%
Income Statement
Revenue $11.04M
Gross Profit $11.01M
Operating Income $-92.11M
EBITDA $-83.44M
Net Income $-88.73M
EPS (Diluted) -$1.41
Revenue / Employee $197.11K
Profit / Employee $-1.58M
Employees 56
Add to Watchlist
Select watchlists to add or remove PYXS